Focal Dystonia Clinical Trial
Official title:
Survey of Sensory and Motor Tricks in Focal Dystonia
This study will collect information on (tricks) patients with focal dystonia use to relieve
their symptoms. Dystonia is a movement disorder caused by sustained muscle contractions
often causing twisting and abnormal posturing. Dystonia may be generalized, affecting at
least one leg and the trunk of the body, segmental, affecting adjacent body parts, or focal,
affecting a single body part, such as the hand or eyelid. It may be task-specific, such as
writer's, musician's or sportsman's cramps. Some patients with focal dystonia use (tricks),
such as touching the face or hand, to stop or alleviate the abnormal movement. This study
will survey the types of tricks people with focal dystonia use in order to learn more about
the disorder.
Patients 18 years of age and older with focal dystonia may be eligible for this study.
Candidates will be screened for eligibility with a medical history, clinical evaluation, and
review of their medical records.
In one 30- to 45-minute clinic visit, participants will be interviewed about their dystonia
symptoms and the tricks they use to relieve the symptoms. They may be asked to show the
investigators how the tricks work
Status | Completed |
Enrollment | 80 |
Est. completion date | February 2005 |
Est. primary completion date | |
Accepts healthy volunteers | No |
Gender | Both |
Age group | N/A and older |
Eligibility |
INCLUSION CRITERIA Patients with focal dystonia diagnosed by review of medical record, history, and clinical evaluation. EXCLUSION CRITERIA Any individual without focal dystonia. Any individual who is unable to provide accurate history, or is critically ill. |
N/A
Country | Name | City | State |
---|---|---|---|
United States | National Institute of Neurological Disorders and Stroke (NINDS) | Bethesda | Maryland |
Lead Sponsor | Collaborator |
---|---|
National Institute of Neurological Disorders and Stroke (NINDS) |
United States,
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04692285 -
Electrophysiological and Neuroimaging Correlates of the Effect of Zolpidem in Patients With Focal Dystonia
|
Phase 1 | |
Completed |
NCT00505323 -
Motor and Premotor Cortex Stimulation for Treatment of Secondary Focal Dystonia With Striato Palliadal Lesion : Evaluation of Safety and Effectiveness
|
Phase 1 | |
Terminated |
NCT03206112 -
Loss of Depotentiation in Focal Dystonia
|
||
Completed |
NCT00025701 -
EEG and EMG Studies of Hand Dystonia
|
N/A | |
Completed |
NCT02334683 -
Compare Two Guidance Techniques for Botulinum Toxin Injections for the Treatment of Limb Spasticity and Focal Dystonia
|
N/A | |
Completed |
NCT03797638 -
Characterization of Manual Dexterity by Finger Force Manipuladum (FFM) in Patients With Writer's Cramp and in Control Subjects
|
N/A | |
Terminated |
NCT01750346 -
Acetyl Hexapeptide-8 for Blepharospasm
|
Phase 2 | |
Completed |
NCT01738581 -
rTMS and Retraining in Focal Hand Dystonia
|
Phase 1/Phase 2 | |
Terminated |
NCT02106936 -
Depotentiation in People With Focal Hand Dystonia
|
N/A | |
Completed |
NCT00310414 -
fMRI Studies of Task Specificity in Focal Hand Dystonia
|
N/A | |
Completed |
NCT00309010 -
Neurophysiology of Task-Specificity of Focal Hand Dystonia
|
N/A | |
Completed |
NCT03471923 -
Non-Motor Features of Cervical Dystonia (CD)
|
||
Completed |
NCT00306865 -
Brain Changes in Patients With Focal Hand Dystonia
|
N/A | |
Completed |
NCT00411255 -
Brain Stimulation to Treat Blepharospasm or Meige Syndrome
|
Phase 2 | |
Terminated |
NCT00487383 -
Brain Changes in Blepharospasm
|
||
Recruiting |
NCT05095740 -
Effects of Neuromodulation in Laryngeal Dystonia
|
N/A | |
Completed |
NCT00713414 -
Role of Neurotransmission and Functional CNS Networks in Spasmodic Dysphonia
|
||
Completed |
NCT00942851 -
A Study of Acetyl Hexapeptide-8 (AH8) in Treatment of Blepharospasm
|
Phase 1/Phase 2 | |
Completed |
NCT00118586 -
Neuropathology of Spasmodic Dysphonia
|
||
Completed |
NCT02326818 -
Comparison of Electrophysiologic and Ultrasound Guidance for Onabotulinum Toxin A Injections in Focal Upper Extremity Dystonia and Spasticity
|
Phase 3 |